Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuki Fukami

Showing results (51-60 of 177) with videos related to

Pageof 18
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 13, 2022
Methionine Sulfoxide Reductase A in Human and Mouse Tissues is Responsible for Sulindac Activation, Making a Larger Contribution than the Gut MicrobiotaKeiya Hirosawa, Tatsuki Fukami, Mai Nagaoka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 24, 2012
Preparation of a specific monoclonal antibody against human UDP-glucuronosyltransferase (UGT) 1A9 and evaluation of UGT1A9 protein levels in human tissuesShingo Oda, Miki Nakajima, Masahiko Hatakeyama, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 10, 2011
Progesterone receptor membrane component 1 modulates human cytochrome p450 activities in an isoform-dependent mannerShingo Oda, Miki Nakajima, Yasuyuki Toyoda, et al.
Toxicology Letters|April 22, 2014
Development of a cell-based assay system considering drug metabolism and immune- and inflammatory-related factors for the risk assessment of drug-induced liver injuryAzusa Yano, Shingo Oda, Tatsuki Fukami, et al.
Biochemical Pharmacology|September 4, 2012
Metabolic activation by human arylacetamide deacetylase, CYP2E1, and CYP1A2 causes phenacetin-induced methemoglobinemiaYuki Kobayashi, Tatsuki Fukami, Ryota Higuchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 30, 2026
Identification of alcohol dehydrogenase (ADH) isoforms catalyzing hydroxyzine oxidation using recombinant human ADH: Serendipitous finding of potent ADH inhibition by organic solventsTakuya Tonami, Rei Sato, Masataka Nakano, et al.
Life Sciences|September 7, 2010
Terbinafine stimulates the pro-inflammatory responses in human monocytic THP-1 cells through an ERK signaling pathwayKatsuhiko Mizuno, Tatsuki Fukami, Yasuyuki Toyoda, et al.
Toxicology|March 7, 2014
Involvement of miRNAs in the early phase of halothane-induced liver injuryShinya Endo, Azusa Yano, Tatsuki Fukami, et al.
The Journal of Biological Chemistry|February 2, 2012
Human α/β hydrolase domain containing 10 (ABHD10) is responsible enzyme for deglucuronidation of mycophenolic acid acyl-glucuronide in liverAtsushi Iwamura, Tatsuki Fukami, Ryota Higuchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 5, 2011
Development of a highly sensitive cytotoxicity assay system for CYP3A4-mediated metabolic activationHiroko Hosomi, Tatsuki Fukami, Atsushi Iwamura, et al.
Pageof 18

Showing results (51-60 of 177) with videos related to

Sort By:
Pageof 18
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 13, 2022
Methionine Sulfoxide Reductase A in Human and Mouse Tissues is Responsible for Sulindac Activation, Making a Larger Contribution than the Gut MicrobiotaKeiya Hirosawa, Tatsuki Fukami, Mai Nagaoka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 24, 2012
Preparation of a specific monoclonal antibody against human UDP-glucuronosyltransferase (UGT) 1A9 and evaluation of UGT1A9 protein levels in human tissuesShingo Oda, Miki Nakajima, Masahiko Hatakeyama, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 10, 2011
Progesterone receptor membrane component 1 modulates human cytochrome p450 activities in an isoform-dependent mannerShingo Oda, Miki Nakajima, Yasuyuki Toyoda, et al.
Toxicology Letters|April 22, 2014
Development of a cell-based assay system considering drug metabolism and immune- and inflammatory-related factors for the risk assessment of drug-induced liver injuryAzusa Yano, Shingo Oda, Tatsuki Fukami, et al.
Biochemical Pharmacology|September 4, 2012
Metabolic activation by human arylacetamide deacetylase, CYP2E1, and CYP1A2 causes phenacetin-induced methemoglobinemiaYuki Kobayashi, Tatsuki Fukami, Ryota Higuchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 30, 2026
Identification of alcohol dehydrogenase (ADH) isoforms catalyzing hydroxyzine oxidation using recombinant human ADH: Serendipitous finding of potent ADH inhibition by organic solventsTakuya Tonami, Rei Sato, Masataka Nakano, et al.
Life Sciences|September 7, 2010
Terbinafine stimulates the pro-inflammatory responses in human monocytic THP-1 cells through an ERK signaling pathwayKatsuhiko Mizuno, Tatsuki Fukami, Yasuyuki Toyoda, et al.
Toxicology|March 7, 2014
Involvement of miRNAs in the early phase of halothane-induced liver injuryShinya Endo, Azusa Yano, Tatsuki Fukami, et al.
The Journal of Biological Chemistry|February 2, 2012
Human α/β hydrolase domain containing 10 (ABHD10) is responsible enzyme for deglucuronidation of mycophenolic acid acyl-glucuronide in liverAtsushi Iwamura, Tatsuki Fukami, Ryota Higuchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 5, 2011
Development of a highly sensitive cytotoxicity assay system for CYP3A4-mediated metabolic activationHiroko Hosomi, Tatsuki Fukami, Atsushi Iwamura, et al.
Pageof 18